Erenumab
Indication
Red
Brand:
Nice TA:
682
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Central nervous system
Background
1.1 Erenumab is recommended as an option for preventing migraine in adults, only if:
-
they have 4 or more migraine days a month
-
at least 3 preventive drug treatments have failed
-
the 140 mg dose of erenumab is used and
-
the company provides it according to the commercial arrangement.